How to buy Tilray shares

Tilray, Inc is a drug manufacturers-specialty & generic business with stocks listed in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$20.22 – an increase of 6.42% over the previous week. Here's how to invest if you're based in Australia.

How to buy shares in Tilray

1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
3. Search for Tilray. Find the share by name or ticker symbol: TLRY. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tilray reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of US$20.22, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Tilray, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Tilray. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Tilray share price

Use our graph to track the performance of TLRY stocks over time.

Tilray shares at a glance

• Key figures

Information last updated 2021-06-09.

52-week range	US$4.41 - US$55.01
50-day moving average	US$16.6194
200-day moving average	US$18.2658
Target price	US$18.98
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	US$-1.23

Compare share trading platforms to buy stock

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Tilray stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Tilray, Inc by TradingView

Tilray price performance over time

Historical closes compared with the last close of $20.22

1 week (2021-06-02)	6.42%
1 month (2021-05-13)	47.81%
3 months (2021-03-12)	-26.66%
6 months (2020-12-11)	160.23%

1 year (2020-06-12)	140.14%
2 years (2019-06-12)	-51.65%

Is Tilray under- or over-valued?

Valuing Tilray stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tilray's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Tilray's EBITDA

Tilray's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$9 million.

The EBITDA is a measure of a Tilray's overall financial performance and is widely used to measure a its profitability.

Tilray financials

Revenue TTM	US$611.1 million
Gross profit TTM	US$191 million
Return on assets TTM	-1.31%
Return on equity TTM	-34.14%
Profit margin	-95.82%
Book value	3.018
Market capitalisation	US$9.6 billion

TTM: trailing 12 months

Shorting Tilray shares

There are currently 30.0 million Tilray shares held short by investors – that's known as Tilray's "short interest". This figure is 13.9% down from 34.8 million last month.

There are a few different ways that this level of interest in shorting Tilray shares can be evaluated.

Tilray's "short interest ratio" (SIR)

Tilray's "short interest ratio" (SIR) is the quantity of Tilray shares currently shorted divided by the average quantity of Tilray shares traded daily (recently around 16.1 million). Tilray's SIR currently stands at 1.86. In other words for every 100,000 Tilray shares traded daily on the market, roughly 1860 shares are currently held short.

However Tilray's short interest can also be evaluated against the total number of Tilray shares, or, against the total number of tradable Tilray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Tilray shares in existence, roughly 80 shares are currently held short) or 0.1939% of the tradable shares (for every 100,000 tradable Tilray shares, roughly 194 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tilray.

Find out more about how you can short Tilray stock.

Tilray share dividends

We're not expecting Tilray to pay a dividend over the next 12 months.

Tilray share price volatility

Over the last 12 months, Tilray's shares have ranged in value from as little as US$4.41 up to US$55.01. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 2.6198. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tilray overview

Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc. and changed its name to Tilray, Inc. Tilray Inc. is based in Leamington, Canada.

Frequently asked questions

• What percentage of Tilray is owned by insiders or institutions?

  Currently 4.808% of Tilray shares are held by insiders and 7.927% by institutions.

• When does the fiscal year end for Tilray?

  Tilray's fiscal year ends in December.

• Where is Tilray based?

  Tilray's address is: 98 Talbot Street West, Leamington, ON, Canada, N8H 1M8

• What is Tilray's ISIN number?

  Tilray's international securities identification number is: US88688T1007

• What is Tilray's CUSIP number?

  Tilray's Committee on Uniform Securities Identification Procedures number is: 88688T100